vs

Side-by-side financial comparison of MERIT MEDICAL SYSTEMS INC (MMSI) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Real Brokerage Inc is the larger business by last-quarter revenue ($568.5M vs $381.9M, roughly 1.5× MERIT MEDICAL SYSTEMS INC). MERIT MEDICAL SYSTEMS INC runs the higher net margin — 10.7% vs -0.1%, a 10.8% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs 7.5%). MERIT MEDICAL SYSTEMS INC produced more free cash flow last quarter ($24.7M vs $8.4M).

Merit Medical Systems Inc. is a global medical device firm that designs, manufactures, and markets a broad portfolio of interventional and diagnostic products used across cardiology, radiology, oncology, endoscopy, and critical care segments. It primarily serves hospitals, clinics, and healthcare providers worldwide, focusing on minimally invasive solutions that enhance patient outcomes and streamline clinical workflows.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

MMSI vs REAX — Head-to-Head

Bigger by revenue
REAX
REAX
1.5× larger
REAX
$568.5M
$381.9M
MMSI
Growing faster (revenue YoY)
REAX
REAX
+45.2% gap
REAX
52.6%
7.5%
MMSI
Higher net margin
MMSI
MMSI
10.8% more per $
MMSI
10.7%
-0.1%
REAX
More free cash flow
MMSI
MMSI
$16.3M more FCF
MMSI
$24.7M
$8.4M
REAX

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
MMSI
MMSI
REAX
REAX
Revenue
$381.9M
$568.5M
Net Profit
$41.0M
$-447.0K
Gross Margin
48.4%
7.9%
Operating Margin
11.6%
-0.1%
Net Margin
10.7%
-0.1%
Revenue YoY
7.5%
52.6%
Net Profit YoY
36.0%
82.7%
EPS (diluted)
$0.68
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MMSI
MMSI
REAX
REAX
Q1 26
$381.9M
Q4 25
$393.9M
Q3 25
$384.2M
$568.5M
Q2 25
$382.5M
$540.7M
Q1 25
$355.4M
$354.0M
Q4 24
$355.2M
Q3 24
$339.8M
$372.5M
Q2 24
$338.0M
Net Profit
MMSI
MMSI
REAX
REAX
Q1 26
$41.0M
Q4 25
$38.0M
Q3 25
$27.8M
$-447.0K
Q2 25
$32.6M
$1.5M
Q1 25
$30.1M
$-5.0M
Q4 24
$27.9M
Q3 24
$28.4M
$-2.6M
Q2 24
$35.7M
Gross Margin
MMSI
MMSI
REAX
REAX
Q1 26
48.4%
Q4 25
49.6%
Q3 25
48.5%
7.9%
Q2 25
48.2%
8.9%
Q1 25
48.4%
9.6%
Q4 24
48.7%
Q3 24
46.4%
8.6%
Q2 24
47.7%
Operating Margin
MMSI
MMSI
REAX
REAX
Q1 26
11.6%
Q4 25
13.8%
Q3 25
11.1%
-0.1%
Q2 25
12.3%
0.3%
Q1 25
11.5%
-1.5%
Q4 24
10.3%
Q3 24
11.0%
-0.7%
Q2 24
13.6%
Net Margin
MMSI
MMSI
REAX
REAX
Q1 26
10.7%
Q4 25
9.6%
Q3 25
7.2%
-0.1%
Q2 25
8.5%
0.3%
Q1 25
8.5%
-1.4%
Q4 24
7.9%
Q3 24
8.4%
-0.7%
Q2 24
10.6%
EPS (diluted)
MMSI
MMSI
REAX
REAX
Q1 26
$0.68
Q4 25
$0.64
Q3 25
$0.46
$0.00
Q2 25
$0.54
$0.01
Q1 25
$0.49
$-0.02
Q4 24
$0.46
Q3 24
$0.48
$-0.01
Q2 24
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MMSI
MMSI
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$488.1M
$38.7M
Total DebtLower is stronger
$735.2M
Stockholders' EquityBook value
$1.6B
$53.6M
Total Assets
$2.7B
$145.2M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MMSI
MMSI
REAX
REAX
Q1 26
$488.1M
Q4 25
$446.4M
Q3 25
$392.5M
$38.7M
Q2 25
$341.8M
$49.7M
Q1 25
$395.5M
$24.7M
Q4 24
$376.7M
Q3 24
$523.1M
$22.6M
Q2 24
$636.7M
Total Debt
MMSI
MMSI
REAX
REAX
Q1 26
$735.2M
Q4 25
$734.0M
Q3 25
$732.9M
Q2 25
$731.8M
Q1 25
$730.7M
Q4 24
$729.6M
Q3 24
$750.5M
Q2 24
$801.3M
Stockholders' Equity
MMSI
MMSI
REAX
REAX
Q1 26
$1.6B
Q4 25
$1.6B
Q3 25
$1.5B
$53.6M
Q2 25
$1.5B
$49.2M
Q1 25
$1.4B
$32.8M
Q4 24
$1.4B
Q3 24
$1.3B
$29.8M
Q2 24
$1.3B
Total Assets
MMSI
MMSI
REAX
REAX
Q1 26
$2.7B
Q4 25
$2.7B
Q3 25
$2.6B
$145.2M
Q2 25
$2.6B
$149.4M
Q1 25
$2.5B
$100.5M
Q4 24
$2.4B
Q3 24
$2.4B
$102.5M
Q2 24
$2.4B
Debt / Equity
MMSI
MMSI
REAX
REAX
Q1 26
0.45×
Q4 25
0.46×
Q3 25
0.48×
Q2 25
0.49×
Q1 25
0.51×
Q4 24
0.53×
Q3 24
0.57×
Q2 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MMSI
MMSI
REAX
REAX
Operating Cash FlowLast quarter
$8.8M
Free Cash FlowOCF − Capex
$24.7M
$8.4M
FCF MarginFCF / Revenue
6.5%
1.5%
Capex IntensityCapex / Revenue
4.2%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$220.8M
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MMSI
MMSI
REAX
REAX
Q1 26
Q4 25
$98.5M
Q3 25
$75.0M
$8.8M
Q2 25
$83.3M
$41.0M
Q1 25
$40.6M
$15.9M
Q4 24
$68.7M
Q3 24
$47.3M
$7.2M
Q2 24
$68.5M
Free Cash Flow
MMSI
MMSI
REAX
REAX
Q1 26
$24.7M
Q4 25
$74.0M
Q3 25
$52.5M
$8.4M
Q2 25
$69.6M
$40.8M
Q1 25
$19.5M
$15.7M
Q4 24
$65.3M
Q3 24
$38.0M
$6.8M
Q2 24
$57.9M
FCF Margin
MMSI
MMSI
REAX
REAX
Q1 26
6.5%
Q4 25
18.8%
Q3 25
13.7%
1.5%
Q2 25
18.2%
7.5%
Q1 25
5.5%
4.4%
Q4 24
18.4%
Q3 24
11.2%
1.8%
Q2 24
17.1%
Capex Intensity
MMSI
MMSI
REAX
REAX
Q1 26
4.2%
Q4 25
6.2%
Q3 25
5.8%
0.1%
Q2 25
3.6%
0.0%
Q1 25
5.9%
0.1%
Q4 24
1.0%
Q3 24
2.8%
0.1%
Q2 24
3.1%
Cash Conversion
MMSI
MMSI
REAX
REAX
Q1 26
Q4 25
2.59×
Q3 25
2.70×
Q2 25
2.56×
27.13×
Q1 25
1.35×
Q4 24
2.46×
Q3 24
1.66×
Q2 24
1.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons